Martin Anne-Marie 4
4 · Cullinan Oncology, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Martin Anne-Marie
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+36,880→ 36,880 totalExercise: $13.99Exp: 2032-02-29→ Common Stock (36,880 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 36,880 shares of the Issuer's Common Stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.